Cimispect 250mg/250mg Injection

产品概览

About Cimispect

Cimispect is a medication containing the active ingredient Imipenem, classified as Carbapenem antibiotic. Imipenem, sold under the brand name Primaxin among others, is a synthetic β-lactam antibiotic belonging to the carbapenems chemical class, developed by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Imipenem and Cilastatin for Injection, USP for intravenous use is a combination of imipenem, a penem antibacterial, and.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Imipenem, the active ingredient in Cimispect, belongs to the Carbapenem antibiotic class. 1 INDICATIONS AND USAGE Imipenem and Cilastatin for Injection, USP for intravenous use is a combination of imipenem, a penem antibacterial, and cilastatin, a renal dehydropeptidase inhibitor, indicated for the treatment of the following serious infections caused by designated susceptible bacteria: Lower respiratory. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Cimispect. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Cimispect for extended periods without medical advice.